Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →Filing growth compares 2021 (262 records) with 2024 (138) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 5,079 records in scope (CR5), not by the ranked leaders only.
Minimally invasive spine access spans the instruments and methods used to reach the spine through small ports rather than open exposure: tubular retractors, dilator systems, percutaneous access kits, and the navigation and imaging integrations that let surgeons work through a narrow channel without direct visualization. The search string used here pulls records that combine an access mechanism — tubular retractor, percutaneous access — with an operative benefit claim such as muscle sparing, reduced blood loss, reduced radiation exposure, or navigation integration. That combination is what separates this landscape from general spinal implant or general endoscopy filings.
5,079 records sit in scope, spanning filings from 2015 through the 2026 cut-off. The set draws heavily on surgical instrumentation classifications, with secondary weight in fluid-handling devices and implants, reflecting how access systems are frequently claimed alongside the delivery or fixation hardware they support.
Two views of the same 5,079-record set: how filing volume has moved year over year, and which IPC subclasses carry the claim weight.
Volume climbed from 164 records in 2017 toward a peak of 289 in 2020, then eased to 262 in 2021 and 138 by 2024 — a -47% move over that three-year span. Because publication trails filing by roughly 18 months, 2025 and 2026 figures are still incomplete and are not evidence of a genuine falloff yet.
A61B (diagnosis & surgery) covers 75.4% of records, far ahead of A61M fluid-device claims (30.3%) and A61F implant claims (25.4%). Sterilization (A61L, 5.3%), electrotherapy (A61N, 4.9%) and image processing (G06T, 1.4%) are present but comparatively thin, which is where less-crowded claim space tends to sit. Records can carry multiple IPC classes, so these shares add to more than 100% of the record total.
Shares are the percentage of the 5,079 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
This page is one run against one query. Ask Eureka your own question about minimally invasive spine access and every answer comes back with the patent numbers behind it.
Try EurekaThe filing describes a surgical kit for minimally invasive spine surgery built around a position-detection system that tracks localizers via sensor signals in its own coordinate frame. A removable sensor carrier sits inside the lumen of a medical instrument and carries at least two localizers, each reporting position and orientation back to the detection system. The kit pairs this tracked carrier with a set of medical instruments sharing a compatible lumen, tying navigation tracking directly to the access instrument rather than to an external frame.Abstract trimmed to the portion describing the tracked-lumen mechanism; the full filing extends the instrument set further.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US6629534B1 | Methods and apparatus for cardiac valve repair | 1,966 |
| 2 | US20100081883A1 | Methods and devices for performing gastroplasties using a multiple port access device | 1,669 |
| 3 | US4862891A | Device for sequential percutaneous dilation | 1,555 |
| 4 | US5797960A | Method and apparatus for thoracoscopic intracardiac procedures | 1,522 |
| 5 | US20090270895A1 | Low advance ratio, high reciprocation rate tissue removal device | 1,518 |
| 6 | US8945163B2 | Methods and devices for cutting and fastening tissue | 1,470 |
| 7 | US7608091B2 | Methods and apparatus for cardiac valve repair | 1,357 |
| 8 | US5855614A | Method and apparatus for thoracoscopic intracardiac procedures | 1,294 |
| 9 | US5830222A | Method for interstitial transvascular intervention | 1,172 |
| 10 | US8128662B2 | Minimally invasive tooling for delivery of interspinous spacer | 1,128 |
Citation counts favour older filings simply because they have had longer to accumulate references; treat them as a signal of influence within this corpus, not of current commercial relevance.
Each row carries its publication number; clicking a row searches Eureka by that number.
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →Three figures worth pulling out of the trend and concentration data before deciding where to file or where to watch.
The leading assignee holds 292 records against a field of 5,079, and the top 5 combined reach only 18.2% of all records in scope. Even the tenth-ranked entrant holds 72 records. That spread means freedom-to-operate analysis has to look well past the obvious leaders.
After peaking at 289 records in 2020, filings dropped from 262 in 2021 to 138 in 2024. Several of the most active historical filers show sharp year-over-year declines in the latest complete year, though publication lag means the very newest years understate true filing activity.
Three-quarters of records touch core surgical instrumentation classification, while image data processing (G06T) appears in only 1.4% of records. That gap is notable given how central navigation integration is to the search criteria — the software and imaging layer is comparatively under-claimed relative to the mechanical access hardware.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to minimally invasive spine access, with the prior art for and against each one.
The ranked list spans 100 companies, from a clear leader down through a long tail of firms with a handful of records each. Recent-year momentum data shows several historically active filers pulling back sharply in the latest year, which is as much a publication-lag artefact as a strategy signal.
The leading assignee's 292 records dwarf the fifth-place count of 107 and the tenth-place count of 72. That gap suggests a company with a broad, defensive filing programme across access hardware rather than a single blocking patent family.
Only 10 co-assignee pairs appear across the dataset, with the strongest pairings linked to individual named inventors rather than institution-to-institution partnerships. This is a field where companies file largely on their own rather than through joint ventures.
Multiple assignees with substantial historical records show latest-year counts at or near zero, with year-over-year drops as steep as -95% to -100%. Given the 18-month publication lag, some of this is filings still working through the pipeline rather than firms exiting the space.
| Assignee | Recent year | YoY |
|---|---|---|
| Auris Health, Inc. | 2 | -95% |
| Onset Medical Corp. | 1 | -67% |
| Silk Road Medical, Inc. | 0 | -100% |
| Warsaw Orthopedic, Inc. | 0 | — |
| Globus Medical, Inc. | 0 | -100% |
| St. Jude Medical Cardiology Division, Inc. | 0 | — |
| Medos International Sarl | 0 | -100% |
| ONSET MEDICAL CORP | 0 | — |
The figures above frame the field; deciding where to file, litigate around, or partner requires drilling into specific claim families and named assignees.
With the top 5 assignees holding only 18.2% of the 5,079 records, a freedom-to-operate check needs to run well past the obvious leaders into the long tail of single- and few-filing entrants.
Explore assignees in EurekaImage processing and navigation-adjacent claims remain thin relative to core access hardware. That gap is worth monitoring as commercial systems increasingly pair tubular access with real-time tracking.
Run a white-space search in EurekaSeveral established filers show sharp pullbacks in the latest year, but publication lag means those figures will keep filling in. Re-check momentum in a future pull before drawing conclusions.
Set up monitoring in EurekaOne assignee leads clearly with 292 records, well ahead of the fifth-ranked company at 107 and the tenth at 72. However, the top 5 assignees combined account for only 18.2% of the 5,079 records in scope, so leadership here is not the same as market lock-up. A large share of filings sit with companies further down a ranked list of 100 assignees, meaning freedom-to-operate work has to look beyond the obvious names.
Filing volume peaked in 2020 at 289 records and has declined since, with 2021's 262 records falling to 138 by 2024, a -47% move. That is a real slowdown across a complete three-year window, not a lag artefact. Figures for 2025 and 2026 are still incomplete because publication trails filing by roughly 18 months, so those most recent years should not yet be read as confirming a continued decline.
Diagnosis and surgery classification (A61B) covers 75.4% of the 5,079 records, making it by far the dominant category. Devices for handling body fluids (A61M) and implants (A61F) follow at 30.3% and 25.4% respectively. Image data processing (G06T) and electrotherapy (A61N) are present but much thinner, at 1.4% and 4.9%, which points to comparatively open claim space in the navigation and energy-delivery layers around access hardware.
The clearest gap sits between the dense mechanical access-hardware claims (tubular retractors, percutaneous dilators) and the comparatively thin software and imaging layer, with only 1.4% of records touching image data processing despite navigation integration being part of the search criteria. Sub-areas such as navigation-to-instrument registration, radiation-exposure-reduction imaging, and blood-loss monitoring during access show up far less often than the core hardware claims. A first claim in these areas would likely combine a sensing or tracking element with the access instrument itself, rather than claiming the mechanical retractor alone.
This filing claims a surgical kit for minimally invasive spine surgery that pairs a position-detection system with a removable sensor carrier placed inside the lumen of a medical instrument. The carrier holds at least two localizers reporting position and orientation back to the detection system, and the kit includes a set of medical instruments sharing a compatible lumen. The practical effect is that navigation tracking is built into the access instrument's own working channel rather than bolted onto an external reference frame, which is the specific mechanism anyone designing a competing navigated-access system needs to review closely.
Go past this page: query the whole minimally invasive spine access corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company's registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.